{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:25:00Z","timestamp":1789925100337,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejrad.2015.02.025","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T10:32:09Z","timestamp":1425637929000},"page":"1128-1136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy"],"prefix":"10.1016","volume":"84","author":[{"given":"Andreas","family":"Stadlbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertold","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertraud","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2015.02.025_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-9966-31-33","article-title":"Early perfusion changes in patients with recurrent high-grade brain tumor treated with bevacizumab: preliminary results by a quantitative evaluation","volume":"31","author":"Vidiri","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0165","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1073\/pnas.1014480108","article-title":"Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma","volume":"108","author":"Keunen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","article-title":"Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0180","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0185","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0190","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0195","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000208958.29600.87","article-title":"MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy","volume":"66","author":"Pope","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0200","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/1471-2407-9-444","article-title":"Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme","volume":"9","author":"Verhoeff","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1148\/radiol.10091341","article-title":"Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging \u2013 pilot study","volume":"255","author":"Sawlani","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0210","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/neuonc\/nos323","article-title":"Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma","volume":"15","author":"LaViolette","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0215","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/neuonc\/not044","article-title":"Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625\/ACRIN 6677","volume":"15","author":"Ratai","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0220","doi-asserted-by":"crossref","first-page":"e56439","DOI":"10.1371\/journal.pone.0056439","article-title":"Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy","volume":"8","author":"Hattingen","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0225","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jmri.23645","article-title":"Brain perfusion imaging: how does it work and what should I use?","volume":"36","author":"McGehee","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0230","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/jcbfm.2010.4","article-title":"A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI","volume":"30","author":"Bjornerud","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0235","first-page":"1989","article-title":"Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging","volume":"24","author":"Law","year":"2003","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0240","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0730-725X(03)00181-4","article-title":"Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy","volume":"21","author":"Li","year":"2003","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0245","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.rli.0000255812.61435.67","article-title":"Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration \u2013 initial results","volume":"42","author":"Stadlbauer","year":"2007","journal-title":"Investig Radiol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/jns.2004.101.2.0287","article-title":"Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging\/magnetic resonance spectroscopy hybrid data set","volume":"101","author":"Stadlbauer","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0255","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0260","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1148\/radiol.2382041896","article-title":"Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging","volume":"238","author":"Stadlbauer","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0265","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/mrm.10640","article-title":"Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3Tesla","volume":"50","author":"Ethofer","year":"2003","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0270","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jmri.20053","article-title":"1H metabolite relaxation times at 3.0Tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation","volume":"19","author":"Traber","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1522-2586(200009)12:3<400::AID-JMRI5>3.0.CO;2-C","article-title":"Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients","volume":"12","author":"Smith","year":"2000","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0280","first-page":"859","article-title":"Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not","volume":"27","author":"Boxerman","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0285","first-page":"1059","article-title":"Perfusion-weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement","volume":"27","author":"Ducreux","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-009-9992-3","article-title":"Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas","volume":"97","author":"Dhermain","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/RMR.0b013e31821e53f5","article-title":"Perfusion MRI using dynamic-susceptibility contrast MRI: quantification issues in patient studies","volume":"21","author":"Calamante","year":"2010","journal-title":"Top Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0300","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3174\/ajnr.A0993","article-title":"Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?","volume":"29","author":"Brasil Caseiras","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0305","doi-asserted-by":"crossref","unstructured":"Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Lalezari S, Zaw T, et al. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol (n.d.);106:111\u2013119.","DOI":"10.1007\/s11060-011-0638-x"},{"key":"10.1016\/j.ejrad.2015.02.025_bib0310","doi-asserted-by":"crossref","unstructured":"Toth V, Forschler A, Hirsch NM, den Hollander J, Kooijman H, Gempt J, et al. MR-based hypoxia measures in human glioma. J Neurooncol (n.d.);115:197\u2013207.","DOI":"10.1007\/s11060-013-1210-7"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X15001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X15001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T18:33:17Z","timestamp":1566412397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X15001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0720048X15001175"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2015.02.025","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2015.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}